Rici Healthcare Holdings Beheer
Beheer criteriumcontroles 4/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Yixin Fang
Algemeen directeur
CN¥571.0k
Totale compensatie
| Percentage CEO-salaris | 84.6% |
| Dienstverband CEO | 5.7yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 5.7yrs |
| Gemiddelde ambtstermijn bestuur | 8.4yrs |
Recente managementupdates
Recent updates
Does Rici Healthcare Holdings (HKG:1526) Have A Healthy Balance Sheet?
Oct 17
Solid Earnings Reflect Rici Healthcare Holdings' (HKG:1526) Strength As A Business
May 01If EPS Growth Is Important To You, Rici Healthcare Holdings (HKG:1526) Presents An Opportunity
Dec 22Returns On Capital Are A Standout For Rici Healthcare Holdings (HKG:1526)
Dec 06Is Rici Healthcare Holdings (HKG:1526) A Risky Investment?
Apr 07Rici Healthcare Holdings' (HKG:1526) Returns On Capital Are Heading Higher
Feb 15Does Rici Healthcare Holdings (HKG:1526) Have A Healthy Balance Sheet?
Dec 15Here's Why Rici Healthcare Holdings (HKG:1526) Has A Meaningful Debt Burden
Sep 13Rici Healthcare Holdings' (HKG:1526) Strong Earnings Are Of Good Quality
May 09Rici Healthcare Holdings (HKG:1526) Has A Somewhat Strained Balance Sheet
Nov 02Rici Healthcare Holdings (HKG:1526) Will Be Hoping To Turn Its Returns On Capital Around
Aug 23These 4 Measures Indicate That Rici Healthcare Holdings (HKG:1526) Is Using Debt Extensively
May 08Rici Healthcare Holdings (HKG:1526) Might Be Having Difficulty Using Its Capital Effectively
Apr 12Is Rici Healthcare Holdings Limited (HKG:1526) Popular Amongst Insiders?
Mar 08Would Shareholders Who Purchased Rici Healthcare Holdings' (HKG:1526) Stock Three Years Be Happy With The Share price Today?
Jan 14Is Rici Healthcare Holdings Limited (HKG:1526) Popular Amongst Insiders?
Nov 23Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥325m |
| Mar 31 2024 | n/a | n/a | CN¥345m |
| Dec 31 2023 | CN¥571k | CN¥483k | CN¥364m |
| Jun 30 2023 | n/a | n/a | CN¥414m |
| Mar 31 2023 | n/a | n/a | CN¥340m |
| Dec 31 2022 | CN¥2m | CN¥282k | CN¥267m |
| Jun 30 2022 | n/a | n/a | CN¥315m |
| Mar 31 2022 | n/a | n/a | CN¥332m |
| Dec 31 2021 | CN¥3m | CN¥311k | CN¥349m |
| Sep 30 2021 | n/a | n/a | CN¥174m |
| Jun 30 2021 | n/a | n/a | CN¥167m |
| Mar 31 2021 | n/a | n/a | CN¥79m |
| Dec 31 2020 | CN¥3m | CN¥321k | -CN¥8m |
| Sep 30 2020 | n/a | n/a | -CN¥90m |
| Jun 30 2020 | n/a | n/a | -CN¥173m |
| Mar 31 2020 | n/a | n/a | -CN¥121m |
| Dec 31 2019 | CN¥4m | CN¥300k | -CN¥69m |
| Sep 30 2019 | n/a | n/a | -CN¥58m |
| Jun 30 2019 | n/a | n/a | -CN¥46m |
| Mar 31 2019 | n/a | n/a | -CN¥50m |
| Dec 31 2018 | CN¥4m | CN¥300k | -CN¥54m |
| Sep 30 2018 | n/a | n/a | -CN¥72m |
| Jun 30 2018 | n/a | n/a | -CN¥91m |
| Mar 31 2018 | n/a | n/a | -CN¥76m |
| Dec 31 2017 | CN¥4m | CN¥300k | -CN¥62m |
Compensatie versus markt: De totale vergoeding ($USD 78.78K ) Yixin } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 336.37K ).
Compensatie versus inkomsten: De vergoeding van Yixin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Yixin Fang (59 yo)
5.7yrs
Tenure
CN¥571,000
Compensatie
Dr. Yixin Fang has been Chief Executive Officer of Rici Healthcare Holdings Ltd since March 20, 2019. Dr. Fang is the Founder of Rici Healthcare Holdings Limited. Dr. Fang serves as the Chairman of Rici He...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 5.7yrs | CN¥571.00k | geen gegevens | |
| COO, VP | no data | CN¥723.00k | geen gegevens | |
| VP & Executive Director | no data | CN¥1.26m | 60.28% HK$ 1.1b | |
| Executive VP | no data | CN¥586.00k | geen gegevens | |
| Chief Financial Officer | 7.5yrs | geen gegevens | geen gegevens | |
| Chief Legal Officer | no data | geen gegevens | geen gegevens | |
| Company Secretary | 4.8yrs | geen gegevens | geen gegevens |
5.7yrs
Gemiddelde duur
45yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 1526 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 8.8yrs | CN¥571.00k | geen gegevens | |
| COO, VP | 5.4yrs | CN¥723.00k | geen gegevens | |
| VP & Executive Director | 10.3yrs | CN¥1.26m | 60.28% HK$ 1.1b | |
| Executive VP | 5.4yrs | CN¥586.00k | geen gegevens | |
| Independent Non-Executive Director | 8.4yrs | CN¥180.00k | geen gegevens | |
| Independent Non-Executive Director | 7.4yrs | CN¥150.00k | geen gegevens | |
| Independent Non-Executive Director | 8.4yrs | CN¥180.00k | geen gegevens |
8.4yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 1526 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.4 jaar).